You have to create each component and put them together to resemble virus particles. Then, these particles, which do not contain genetic material, are delivered into the body as a vaccine.
You can check it out at other institutions that have formulated a vaccine using the Virus-like Particle method.
Good one!
Your choice is shared by 10 other institutions who are known to be using this method by the end of June, 2020. It has led to the successful creation of the HPV vaccine. However, every SARS-CoV2 vaccine candidate being developed using this strategy is still in a pre-clinical trials.
You can still pick the Virus-like Particle method, or change to a different strategy.
A company called Medicago is currently developing this sort of vaccine. You can opt to collaborate with them or else do things on your own.
Whoops, we haven’t established cooperation with any institution.
You can try to collaborate Remember though, time is not on your side.
You will have to start from the very beginning. If you’re sure about this, you may continue. Otherwise, you might want to collaborate with others.
It is possible to develop this kind of vaccine cooperatively. But the thing is, the candidates are still in pre-clinical trials and they still need a long time to be ready. You can cooperate with several parties, including the institutions currently developing the vaccine, but you must always consider the potential benefits from such collaboration.
Feeling like it’s not the best way? You can take a look at other strategies.
This choice puts you in a challenging situation. No institution in Indonesia is yet planning to develop a vaccine using this approach. You can try to persuade them, but your chance of meeting the 12-month deadline is slim.
View other strategies.
Published:
Copyright 2020. Kompas.com
